Pulmonary Hypertension News Forums Forums PH Care and Treatment Treatments and Therapies PAH therapy Uptravi recommended for use through Scotland’s NHS

  • PAH therapy Uptravi recommended for use through Scotland’s NHS

    Posted by pulmonary-hypertension-news-moderator on May 24, 2018 at 5:13 pm

    Scottish patients with pulmonary arterial hypertension (PAH) can now be treated with Actelion‘s Uptravi (selexipag) through the country’s National Health System (NHS) after a positive recommendation from the Scottish Medicines Consortium (SMC). However, the use of this therapy will be restricted to adult patients in WHO functional class 3 whose symptoms are not manageable or do not tolerate other available PAH therapies.

    Read more about this story here: Scottish Agency Recommends Uptravi for PAH Treatment Through National Health System

     

    Have you heard of selexipag? What do you think of this news?

    replied 5 years, 10 months ago 1 Member · 0 Replies
  • 0 Replies

Sorry, there were no replies found.

Log in to reply.